According to
Real-world claims data
86
%
OF VILTEPSO PATIENTS*
Remained on treatment
after 12 months1
*In an eligible cohort
Reference: 1. Data on File. NS Pharma, Inc.; 2025. © 2025 NS Pharma, Inc. All rights reserved. NS Pharma and the symbol for NS Pharma are registered trademarks of Nippon Shinyaku Co., Ltd. Viltepso is a registered trademark of Nippon Shinyaku Co., Ltd. 10/25 US-NS65C-1808